Return On Equity of FibroBiologics, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit: ratio: %
Description: Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary: FibroBiologics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2023 to 31 Dec 2025.
FibroBiologics, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -786%, a 114% decline year-over-year.
FibroBiologics, Inc. annual Return On Equity for 2025 was -786%, a 114% decline from 2024.
FibroBiologics, Inc. annual Return On Equity for 2024 was 5738%.

Return On Equity, Quarterly (%)

Return On Equity, YoY Quarterly Change (%)

Return On Equity, Annual (%)

Return On Equity, YoY Annual Change (%)

FibroBiologics, Inc. Quarterly Return On Equity (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q4 2025	-786%	-6524%	-114%	01 Oct 2025	31 Dec 2025
Q3 2025	-1219%	-4366%	-139%	01 Jul 2025	30 Sep 2025
Q2 2025	-609%	+796%	+57%	01 Apr 2025	30 Jun 2025
Q1 2025	-564%	-97%	-21%	01 Jan 2025	31 Mar 2025
Q4 2024	5738%	+6016%		01 Oct 2024	31 Dec 2024
Q3 2024	3147%			01 Jul 2024	30 Sep 2024
Q2 2024	-1406%			01 Apr 2024	30 Jun 2024
Q1 2024	-467%			01 Jan 2024	31 Mar 2024
Q4 2023	-277%			01 Oct 2023	31 Dec 2023

Period	Value	YoY Chg	Change %	Start Date	End Date
2025	-786%	-6524%	-114%	01 Jan 2025	31 Dec 2025
2024	5738%	+6016%		01 Jan 2024	31 Dec 2024
2023	-277%			01 Jan 2023	31 Dec 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.